§ 13F · FUND PROFILE
Sanofi.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $175.7T (13F)Positions · 10Turnover · — · Q4Filed · Feb 11, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$16.0T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 11, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | MGTX | MeiraGTx Holdings plc | 12.20M | $97.0T | 31.2% | ±0% |
| 2 | INBX | Inhibrx Biosciences, Inc. | 1.16M | $91.5T | 29.5% | ±0% |
| 3 | NVAX | Novavax | 6.88M | $46.2T | 14.9% | ±0% |
| 4 | ANAB | AnaptysBio | 822K | $39.8T | 12.8% | ±0% |
| 5 | IMRX | Immuneering Corp | 2.71M | $17.8T | 5.7% | ±0% |
| 6 | MPLT | MapLight Therapeutics Inc. | 912K | $16.0T | 5.2% | NEW |
| 7 | ELDN | Eledon | 815K | $1.2T | 0.4% | ±0% |
| 8 | QTTB | Q32 Bio Inc. | 244K | $810.4B | 0.3% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE SANOFI SIGNAL
AC read
Sanofi is a Other fund managing $175742.8 trillion in assets. The fund runs a focused portfolio of just 10 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed